Dose-escalated radiotherapy improved survival for esophageal cancer patients with a clinical complete response after standard-dose radiotherapy with concurrent chemotherapy

References

• TorreLABrayFSiegelRLFerlayJLortet-TieulentJJemalAGlobal cancer statistics, 2012CA Cancer J Clin20156528710825651787
   PubMed Web of Science ®Google Scholar
• FerlayJShinHRBrayFFormanDMathersCParkinDMEstimates of worldwide burden of cancer in 2008: GLOBOCAN 2008Int J Cancer2010127122893291721351269
   PubMed Web of Science ®Google Scholar
• WheelerJBReedCEEpidemiology of esophageal cancerSurg Clin North Am20129251077108723026270
   PubMed Web of Science ®Google Scholar
• ShahbazSCMLuketichJDLandreneauRJAbbasGEsophageal cancer: an updateInt J Surg20108641742220601255
   PubMed Web of Science ®Google Scholar
• CooperJSGuoMDHerskovicAChemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology GroupJAMA1999281171623162710235156
   PubMed Web of Science ®Google Scholar
• YenYCChangJHLinWCEffectiveness of esophagectomy in patients with thoracic esophageal squamous cell carcinoma receiving definitive radiotherapy or concurrent chemoradiotherapy through intensity-modulated radiation therapy techniquesCancer2017123112043205328152166
   PubMed Web of Science ®Google Scholar
• MinskyBDPajakTFGinsbergRJINT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapyJ Clin Oncol20022051167117411870157
   PubMed Web of Science ®Google Scholar
• ZhangZLiaoZJinJDose-response relationship in locoregional control for patients with stage II-III esophageal cancer treated with concurrent chemotherapy and radiotherapyInt J Radiat Oncol Biol Phys200561365666415708243
   PubMed Web of Science ®Google Scholar
• SeungSKSmithJWMolendykJSelective dose escalation of chemoradiotherapy for esophageal cancer: role of treatment intensificationSemin Oncol2004316 Suppl 181319
   PubMed Web of Science ®Google Scholar
• SuhYGLeeIJKoomWSHigh-dose versus standard-dose radiotherapy with concurrent chemotherapy in stages II–III esophageal cancerJpn J Clin Oncol201444653454024771865
   PubMed Web of Science ®Google Scholar
• MaJWangZWangCIndividualized radiation dose escalation based on the decrease in tumor FDG uptake and normal tissue constraints improve survival in patients with esophageal carcinomaTechnol Cancer Res Treat2017161758026834115
   PubMed Web of Science ®Google Scholar
• Di FioreFLecleireSRigalOPredictive factors of survival in patients treated with definitive chemoradiotherapy for squamous cell esophageal carcinomaWorld J Gastroenterol200612264185419016830371
   PubMed Web of Science ®Google Scholar
• YamashitaHOkumaKWakuiRKobayashi-ShibataSOhtomoKNakagawaKDetails of recurrence sites after elective nodal irradiation (ENI) using 3D-conformal radiotherapy (3D-CRT) combined with chemotherapy for thoracic esophageal squamous cell carcinoma – a retrospective analysisRadiother Oncol201198225526021074880
   PubMed Web of Science ®Google Scholar
• OnozawaMNiheiKIshikuraSElective nodal irradiation (ENI) in definitive chemoradiotherapy (CRT) for squamous cell carcinoma of the thoracic esophagusRadiother Oncol200992226626918952308
   PubMed Web of Science ®Google Scholar
• HeLAllenPKPotterARe-evaluating the optimal radiation dose for definitive chemoradiotherapy for esophageal squamous cell carcinomaJ Thorac Oncol2014991398140525122435
   PubMed Web of Science ®Google Scholar
• KimHJSuhYGLeeYCDose-response relationship between radiation dose and loco-regional control in patients with stage II–III esophageal cancer treated with definitive chemoradiotherapyCancer Res Treat201749366967727737537
   PubMed Web of Science ®Google Scholar
• ChenCYLiCCChienCRDoes higher radiation dose lead to better outcome for non-operated localized esophageal squamous cell carcinoma patients who received concurrent chemoradiotherapy? A population based propensity-score matched analysisRadiother Oncol2016120113613927207358
   PubMed Web of Science ®Google Scholar
• SudoKTaketaTCorreaAMLocoregional failure rate after preoperative chemoradiation of esophageal adenocarcinoma and the outcomes of salvage strategiesJ Clin Oncol201331344306431024145339
   PubMed Web of Science ®Google Scholar
• RohatgiPRSwisherSGCorreaAMFailure patterns correlate with the proportion of residual carcinoma after preoperative chemoradiotherapy for carcinoma of the esophagusCancer200510471349135516130133
   PubMed Web of Science ®Google Scholar
• SmitJKGülerSBeukemaJCDifferent recurrence pattern after neoadjuvant chemoradiotherapy compared to surgery alone in esophageal cancer patientsAnn Surg Oncol201320124008401523838922
   PubMed Web of Science ®Google Scholar
• McLoughlinJMMelisMSiegelEMAre patients with esophageal cancer who become PET negative after neoadjuvant chemoradiation free of cancerJ Am Coll Surg20082065879886 discussion 886–88718471715
   PubMed Web of Science ®Google Scholar
• StilesBMSalzlerGJorgensenAComplete metabolic response is not uniformly predictive of complete pathologic response after induction therapy for esophageal cancerAnn Thorac Surg20139651820182523895888
   PubMed Web of Science ®Google Scholar
• SchneiderPMMetzgerRSchaeferHResponse evaluation by endoscopy, rebiopsy, and endoscopic ultrasound does not accurately predict histopathologic regression after neoadjuvant chemoradiation for esophageal cancerAnn Surg2008248690290819092334
   PubMed Web of Science ®Google Scholar
• SarkariaISRizkNPBainsMSPost-treatment endoscopic biopsy is a poor-predictor of pathologic response in patients undergoing chemoradiation therapy for esophageal cancerAnn Surg2009249576476719387328
   PubMed Web of Science ®Google Scholar
• KimMPCorreaAMLeeJPathologic T0N1 esophageal cancer after neoadjuvant therapy and surgery: an orphan statusAnn Thorac Surg2010903884890 discussion 890–89120732513
   PubMed Web of Science ®Google Scholar